Prime Highlights:
- Yikon Genomics launches its first lab in Malaysia to improve reproductive and preventive healthcare across the Asia-Pacific region.
- The lab will work with local hospitals, fertility centers, and research institutions to strengthen healthcare services.
Key Facts:
- The facility provides specialized tests for reproductive and inherited health conditions.
- This initiative positions Malaysia as a growing hub for advanced genetic research and services in Asia.
Background:
Yikon Genomics has opened its first lab in Malaysia, aiming to improve reproductive and preventive healthcare in the Asia-Pacific region.
The lab will provide tests for reproductive and inherited health conditions and collaborate with local hospitals, fertility centers, and research institutions to support healthcare growth.
Dr. Sijia Lu, Yikon’s founder and CEO, said that the new lab is an important step for the company in the region and will make advanced genetic testing and preventive healthcare easier, more affordable, and more beneficial for families.
Dr. Lu highlighted that the lab will support local labs, improve preventive healthcare, and strengthen communities. He added that prioritizing prevention over treatment will help families stay healthier and create stronger healthcare systems.
Dr. David Wong, lab manager at Yikon Genomics Malaysia, said the lab shows the company’s dedication to reproductive genetics and precision medicine. With advanced sequencing technology and an expert team, the facility helps local partners improve skills and speed up scientific and medical progress in the Asia-Pacific region.
Yikon Genomics focuses on reproductive genetics, personalized medicine, and public health. The company uses modern DNA methods to test for genetic conditions, including embryo screening and checking disease risks.
The new Kuala Lumpur lab will boost healthcare and make preventive services easier to access, making Malaysia a genetic research hub.
